Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

531 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Imaging medullary cystic kidney disease with magnetic resonance.
Meier P, Farres MT, Mougenot B, Jacob L, Le Goas F, Antignac C, Ronco P. Meier P, et al. Among authors: ronco p. Am J Kidney Dis. 2003 Jul;42(1):E5-10. doi: 10.1016/s0272-6386(03)00426-8. Am J Kidney Dis. 2003. PMID: 12830488
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.
Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, Michel PA, Mihout F, Dussol B, Matignon M, Mousson C, Simon T, Ronco P; GEMRITUX Study Group. Dahan K, et al. Among authors: ronco p. J Am Soc Nephrol. 2017 Jan;28(1):348-358. doi: 10.1681/ASN.2016040449. Epub 2016 Jun 27. J Am Soc Nephrol. 2017. PMID: 27352623 Free PMC article. Clinical Trial.
HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy.
Wang HY, Cui Z, Xie LJ, Zhang LJ, Pei ZY, Chen FJ, Qu Z, Huang J, Zhang YM, Wang X, Wang F, Meng LQ, Cheng XY, Liu G, Zhou XJ, Zhang H, Debiec H, Ronco P, Zhao MH. Wang HY, et al. Among authors: ronco p. Kidney Int. 2018 Nov;94(5):974-982. doi: 10.1016/j.kint.2018.06.005. Epub 2018 Aug 30. Kidney Int. 2018. PMID: 30173899
531 results